GEXVal Participates in “Venture Innovation Pavilion2022”
2022/7/7
GEXVal Inc. July 7, 2022 GEXVal will participate in the Venture Innovation Pavilion at PharmaLab EXPO JAPAN 2 […]
HREC Approval of the Initiation of Phase 1 Study of GXV-001 in Australia
2022/6/10
GEXVal Inc.June 10, 2022 GEXVal Inc. has invited experienced doctors and specialists from Japan, Australia, Sw […]
Announcement of the 299th Japan Pharmaceutical Licensing Association (JPLA) Regular Meeting
2022/2/24
GEXVal Inc.February 24, 2022 Announcement of the 299th Japan Pharmaceutical Licensing Association (JPLA) Regul […]